Case-Based Review : newly diagnosed glioblastoma

Neuro-oncology Practice
Derek R JohnsonJennifer Clarke

Abstract

Glioblastoma (WHO grade IV astrocytoma) is the most common and most aggressive primary brain tumor in adults. Optimal treatment of a patient with glioblastoma requires collaborative care across numerous specialties. The diagnosis of glioblastoma may be suggested by the symptomatic presentation and imaging, but it must be pathologically confirmed via surgery, which can have dual diagnostic and therapeutic roles. Standard of care postsurgical treatment for newly diagnosed patients involves radiation therapy and oral temozolomide chemotherapy. Despite numerous recent trials of novel therapeutic approaches, this standard of care has not changed in over a decade. Treatment options under active investigation include molecularly targeted therapies, immunotherapeutic approaches, and the use of alternating electrical field to disrupt tumor cell division. These trials may be aided by new insights into glioblastoma heterogeneity, allowing for focused evaluation of new treatments in the patient subpopulations most likely to benefit from them. Because glioblastoma is incurable by current therapies, frequent clinical and radiographic assessment is needed after initial treatment to allow for early intervention upon progressive tumor when it o...Continue Reading

References

Jul 1, 1976·Archives of Neurology·W R Shapiro, D F Young
Oct 1, 1979·International Journal of Radiation Oncology, Biology, Physics·M D WalkerG E Sheline
Oct 1, 1979·International Journal of Radiation Oncology, Biology, Physics·O M SalazarR Pizzutiello
Nov 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·N SugawaV P Collins
Jul 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D R MacdonaldJ G Cairncross
Feb 15, 1995·International Journal of Radiation Oncology, Biology, Physics·D D Roman, P W Sperduto
Mar 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J R CrossenE A Neuwelt
Jan 1, 1993·Journal of Neuropathology and Experimental Neurology·D N LouisB R Seizinger
Nov 9, 2000·The New England Journal of Medicine·M EstellerJ G Herman
Jul 11, 2003·The New England Journal of Medicine·Agnes Y Y LeeUNKNOWN Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Veno
Sep 10, 2003·Journal of Neurosurgery·Edward R LawsUNKNOWN Glioma Outcomes Investigators
Oct 7, 2004·Cancer Research·Hiroko OhgakiPaul Kleihues
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Mar 11, 2005·The New England Journal of Medicine·Monika E HegiRoger Stupp
Apr 5, 2005·Proceedings of the National Academy of Sciences of the United States of America·Bradford A MoffatBrian D Ross
Oct 11, 2007·Journal of the National Cancer Institute·Eleni LinosDominique Michaud
Jan 4, 2008·The New England Journal of Medicine·Nader SanaiMitchel S Berger
Apr 17, 2008·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Yuzo TerakawaKenji Ohata
May 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alba A BrandesMario Ermani
May 3, 2008·The Lancet Oncology·Dieta BrandsmaMartin J van den Bent
May 23, 2008·Neurosurgery·Nader Sanai, Mitchel S Berger
May 31, 2008·European Journal of Radiology·Carlos J LedezmaWhitney Pope
Sep 6, 2008·Science·D Williams ParsonsKenneth W Kinzler
Oct 14, 2008·Journal of Neurosurgery·Matthew J McGirtAlf Redo Quiñones-Hinojosa
Feb 18, 2009·Journal of Neuro-oncology·Elizabeth R GerstnerPatrick Y Wen
Feb 21, 2009·The New England Journal of Medicine·Hai YanDarell D Bigner
Apr 10, 2009·Journal of Neuro-oncology·Susan M ChangMitchel Berger
Jul 21, 2009·Journal of Neurosurgery·Nader SanaiMitchel S Berger

❮ Previous
Next ❯

Citations

Nov 9, 2019·BMJ : British Medical Journal·Shing Fung LeeFrank Chi Sing Wong
Sep 27, 2016·Clinical Journal of Oncology Nursing·Mary Elizabeth Davis
Feb 23, 2021·Frontiers in Oncology·Bryan OronskySusan J Knox
Sep 19, 2020·ACS Chemical Neuroscience·Mahendran BhaskaranThirumalaraju Vaishnavi
Aug 31, 2021·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Leonardo Delello Di FilippoMarlus Chorilli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Related Papers

Archives of Neurology
Jennifer ClarkeSusan M Chang
Future Oncology
Evidio Domingo-Musibay, Evanthia Galanis
Anti-cancer Agents in Medicinal Chemistry
Sith Sathornsumetee
© 2021 Meta ULC. All rights reserved